In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report). The company’s ...

B. Riley analyst Kyle Bauser raised the firm’s price target on ClearPoint Neuro (CLPT) to $20 from $15 and keeps a Buy rating on the shares.

ClearPoint Navigation Software Version 3.0 introduces an intraoperative CT workflow that builds on over a decade of experience in enabling MRI-guided stereotactic procedures. While previous ...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...

ClearPoint Navigation Software Version 3.0 introduces an intraoperative CT workflow that builds on over a decade of experience in enabling MRI-guided stereotactic procedures.

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...

Bras get a bad rap because it’s hard to find one that lifts and separates without looking unnatural, and provides support without feeling uncomfortable. But the longer I’ve been on the bra ...

Cotton Blend: Made with a blend of 57% Cotton, 38% Modal, and 5% Spandex, these bralettes offer a perfect balance of softness and stretch for all-day comfort. Your child will adore the cozy ...

Getting life insurance typically requires a medical exam to give your provider a clearer picture of your health status. But there are policies available that don't require an examination.

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma ...

Cuup was founded on the basis that the majority of women wear the wrong bra size, largely thanks to old-school lingerie brands that confined women to a small and unrealistic range of fits.